Increased nuchal translucency, normal karyotype and infant development

Ultrasound in Obstetrics and Gynecology

Volumn 39, Issue 1, 2012, Pages 28-33

  Miltoft, C B ^a   Ekelund, C K ^a   Hansen, B M ^a   Lando, A ^a   Petersen, O B ^b   Skovbo, P ^c   Jorgensen F S ^d,e   Sperling, L ^f   Zingenberg, H ^f   Nikkila A ^g   Shalmi, A C ^f   Stornes, I ^h   Ersbak, V ⁱ   Tabor, A ^a,d  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

^f Mental Health Services CPH   (Denmark)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h RANDERS REGIONAL HOSPITAL   (Denmark)

ⁱ SILKEBORG REGIONAL HOSPITAL   (Denmark)

Author keywords

ASQ; first trimester screening; infant development; neurodevelopmental delay; NT

Indexed keywords

ADULT; ARTICLE; CHILD DEVELOPMENT; CLINICAL TRIAL; DENMARK; DEVELOPMENTAL DISORDER; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GENETICS; HUMAN; KARYOTYPING; MALE; METHODOLOGY; MULTICENTER STUDY; NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; TIME;

ADULT; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DENMARK; DEVELOPMENTAL DISABILITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; KARYOTYPING; MALE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TIME FACTORS;

EID: 84555193015     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.10060     Document Type: Article

References (33)

1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K,. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869.
2. Snijders RJ, Johnson S, Sebire NJ, Noble PL, Nicolaides KH,. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996; 7: 216-226. (Pubitemid 126720367)
3. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH,. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346. (Pubitemid 28352196)
4. Szabõ J, Gellén J, Szemere G,. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age. Ultrasound Obstet Gynecol 1995; 5: 161-163.
5. Taipale P, Hiilesmaa V, Salonen R, Ylostalo P,. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997; 337: 1654-1658. (Pubitemid 27510102)
6. Ville Y, Lalondrelle C, Doumerc S, Daffos F, Frydman R, Oury JF, Dumez Y,. First-trimester diagnosis of nuchal anomalies: significance and fetal outcome. Ultrasound Obstet Gynecol 1992; 2: 314-316.
7. Danish National Board of Health. Report from a working commission "Prenatal diagnosis and risk assessment", 2003. http://www.sst.dk/ upload/fosterdiagnostik1001.pdf.2003
8. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH,. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81-85. (Pubitemid 29188923)
9. Michailidis GD, Economides DL,. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001; 17: 102-105.
10. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH,. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11: 391-400. (Pubitemid 28344740)
11. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH,. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001; 18: 9-17.
12. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH,. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192: 1005-1021. (Pubitemid 40487772)
13. Westin M, Saltvedt S, Almström H, Grunewald C, Valentin L,. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16 260 fetuses derived from an unselected pregnant population. Ultrasound Obstet Gynecol 2007; 29: 150-158. (Pubitemid 46326587)
14. Adekunle O, Gopee A, el-Sayed M, Thilaganathan B,. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population. Br J Radiol 1999; 72: 457-460. (Pubitemid 29241582)
15. Bilardo CM, Muller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK,. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 2007; 30: 11-18. (Pubitemid 47074846)
16. Brady AF, Pandya PP, Yuksel B, Greenough A, Patton MA, Nicolaides KH,. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation. J Med Genet 1998; 35: 222-224. (Pubitemid 28159927)
17. Cheng CC, Bahado-Singh RO, Chen SC, Tsai MS,. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening. Int J Gynaecol Obstet 2004; 84: 5-9. (Pubitemid 38064136)
18. Hiippala A, Eronen M, Taipale P, Salonen R, Hiilesmaa V,. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study. Ultrasound Obstet Gynecol 2001; 18: 18-22.
19. Maymon R, Jauniaux E, Cohen O, Dreazen E, Weinraub Z, Herman A,. Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency. Hum Reprod 2000; 15: 2023-2027.
20. Mula R, Goncé A, Arigita M, Meler E, Nadal A, Sánchez A, Botet F, Borrell A,. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcome at two years of age. Ultrasound Obstet Gynecol 2011; Aug 11; DOI: 10.1002/uog.10059 [Epub ahead of print].
21. Schou KV, Kirchhoff M, Nygaard U, Jorgensen C, Sundberg K,. Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses. Ultrasound Obstet Gynecol 2009; 34: 618-622.
22. Senat MV, De Keersmaecker B, Audibert F, Montcharmont G, Frydman R, Ville Y,. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn 2002; 22: 345-349. (Pubitemid 34538557)
23. Senat MV, Bussières L, Couderc S, Roume J, Rozenberg P, Bouyer J, Ville Y,. Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study. Am J Obstet Gynecol 2007; 196: 53.e1-6.
24. Van Vugt JM, Tinnemans BW, Van Zalen-Sprock RM,. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation. Ultrasound Obstet Gynecol 1998; 11: 407-409. (Pubitemid 28344742)
25. Bilardo CM, Timmerman E, Pajkrt E, van Maarle M,. Increased nuchal translucency in euploid fetuses-what should we be telling the parents? Prenat Diagn 2010; 30: 93-102.
26. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH,. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
27. Squires J, Potter L, Bricker D,. The ASQ User's Guide (2nd edn). Paul Brookes Publishing: Baltimore, 1999.
28. Gollenberg AL, Lynch CD, Jackson LW, McGuinness BM, Msall ME,. Concurrent validity of the parent-completed Ages and Stages Questionnaires, 2nd Ed. with the Bayley Scales of Infant Development II in a low-risk sample. Child Care Health Dev 2010; 36: 485-490.
29. Marlow N, Wolke D, Bracewell MA, Samara M,. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005; 352: 9-19. (Pubitemid 40075676)
30. Kerstjens JM, Bos AF, ten Vergert EM, de Meer G, Butcher PR, Reijneveld SA,. Support for the global feasibility of the Ages and Stages Questionnaire as developmental screener. Early Hum Dev 2009; 85: 443-447.
31. Richter J, Janson H,. A validation study of the Norwegian version of the Ages and Stages Questionnaires. Acta Paediatr 2007; 96: 748-752. (Pubitemid 46653182)
32. Rode L, Ekelund C, Pedersen NG, Wøjdemann KR, Christiansen M, Sundberg K, Tabor A,. Maternal smoking, obesity and male fetal sex predispose to a large nuchal translucency thickness in healthy fetuses. Fetal Diagn Ther 2011; 29: 201-207.
33. Timmerman E, Pajkrt E, Bilardo CM,. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency. Ultrasound Obstet Gynecol 2009; 34: 373-378.